Roche Receives CE Mark for Accu-Chek SugarView Smartphone App
The app will enable broader access to therapy-relevant information for non-insulin-dependent people with type 2 diabetes or prediabetes.
Read MorePosted by | Feb 7, 2020 | POC Instruments, Point-of-Care |
The app will enable broader access to therapy-relevant information for non-insulin-dependent people with type 2 diabetes or prediabetes.
Read MorePosted by Steve Halasey | Jan 10, 2020 | Breast, Lung Cancer, Sepsis |
T2 Biosystems has announced the appointment of diagnostics industry veteran John Sperzel as president and chief executive officer, succeeding John McDonough, who will continue with his board leadership role, serving as nonexecutive chairman.
Read MorePosted by | Jan 9, 2020 | Research |
Inflammatix’s HostDx fever test reads the immune system to rapidly diagnose acute infections at the point of care.
Read MorePosted by | Dec 30, 2019 | Microarray Systems, POC Instruments, Point-of-Care |
SpeeDx and the QuantuMDx Group are collaborating with the Foundation for Innovative New Diagnostics to assess the feasibility of developing low-cost, point-of-care tests for common sexually transmitted infections.
Read MoreThe Navify guidelines app pulls the latest clinical guidance for breast, colorectal, non-small cell lung, and prostate cancers from the National Comprehensive Cancer Network.
Read More